Rocket Pharmaceuticals Currently Up Nine Days Straight, On Pace for Longest Winning Streak Since August 2018 -- Data Talk

Dow Jones
Feb 26

Rocket Pharmaceuticals, Inc. ( RCKT ) is currently at $4.32, up $0.08 or 1.76%

 

--Would be highest close since May 23, 2025, when it closed at $6.27

--On pace for largest percent increase since Feb. 24, 2026, when it rose 6.52%

--Currently up 12 of the past 13 days

--Currently up nine consecutive days; up 33.49% over this period

--Longest winning streak since Aug. 31, 2018, when it rose for 12 straight trading days

--Best nine day stretch since the nine days ending Oct. 14, 2025, when it rose 35.13%

--Up 24.28% month-to-date; on pace for best month since July 2025, when it rose 24.49%

--Up 23.22% year-to-date

--Down 93.87% from its all-time closing high of $70.60 on July 24, 2015

--Down 54.57% from 52 weeks ago (Feb. 26, 2025), when it closed at $9.52

--Down 54.57% from its 52-week closing high of $9.52 on Feb. 26, 2025

--Up 85.62% from its 52-week closing low of $2.33 on May 27, 2025

--Traded as high as $4.45; highest intraday level since Oct. 15, 2025, when it hit $4.51

--Up 4.71% at today's intraday high

 

All data as of 2:15:20 PM ET

 

Source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

February 25, 2026 14:26 ET (19:26 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10